GlassScriptPhysician profile
Aliza Bram
NPI 1558863712
$3,768.08
in general payments reported to CMS, 2019-2025
20 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $210 · 2023: $813 · 2024: $1,265 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,281 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,281.30 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,087.39 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $386.64 | 2023-2025 | Zoryve |
| Pfizer INC. | $354.29 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $328.52 | 2023-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $284.85 | 2022-2024 | Sotyktu |
| Amgen INC. | $233.96 | 2021-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $180.00 | 2022-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $176.99 | 2023-2025 | |
| Janssen Biotech, INC. | $105.79 | 2024-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $96.06 | 2021-2025 | |
| Journey Medical Corporation | $94.48 | 2023-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $90.68 | 2021-2023 | Jublia, Arazlo, Duobrii |
| Botanix Sb INC | $72.16 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $68.86 | 2021-2023 | Absorica Ld, Winlevi |
| Leo Pharma INC. | $61.42 | 2024-2025 | Anzupgo, Adbry |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $52.42 | 2024-2025 | Bimzelx |
| Epi Health, LLC | $49.90 | 2021-2022 | |
| Dermavant Sciences, INC. | $16.39 | 2023 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $15.02 | 2022 | |
| Almirall LLC | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aliza Bram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.